2001 Nov 29 [updated 2021 Feb 11]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
PMID:20301661
Colonic angiodysplasia.
Foutch PG.
Gastroenterologist. 1997 Jun;5(2):148-56.
PMID:9193932
Inhibition of endogenous nitric oxide activity impairs the colonic sparing effect of rofecoxib, the cyclooxygenase-2 inhibitor and resveratrol, the preferential cyclooxygenase-1 inhibitor in the course of experimental colitis. Role of oxidative stress biomarkers and proinflammatory cytokines.
Kwiecień S, Wojcik-Grzybek D, Sliwowski Z, Targosz A, Chmura A, Magierowska K, Strzalka M, Glowacka U, Ptak-Belowska A, Magierowski M, Brzozowski T.